Pharmaceutical Investing

Gloved hands preparing a syringe with a vial in a lab setting.

Biotech and Pharma Market Update: Q1 2025 in Review

The healthcare sector faced a whirlwind of challenges and opportunities in Q1, from major acquisitions to regulatory uncertainties. What will Q2 bring for biotech and pharma?

Life Science Investing News
Latest Articles

Trump Signs Sweeping Order to Slash Drug Prices, Pressure Pharma Giants

Pharmaceutical Investing

5 Biggest Pharmaceutical ETFs in 2025

Pharmaceutical Investing

Top 5 Small-cap Pharma Stocks in 2025

Pharmaceutical Investing

Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

Life Science Investing News

What is In-Licensing?

Pharmaceutical Investing

Amgen, Merck and Pfizer Release Latest Quarterly Earnings, Share 2025 Plans

Pharmaceutical Investing
Company Profiles
CRDL:CA

Cardiol Therapeutics

Heal the heart with innovative science.

Pharmaceutical Investing
More Companies
CEO Interviews

Sirona Biochem Eyes 2025 Launch of New Anti-aging Product

Biotech Investing

"Wrap-around Care" Model Helps Address Gaps in Mental Healthcare

Pharmaceutical Investing

Orphan Drug Development an Exciting Opportunity to Provide Superior Therapeutics, Lobe Sciences CEO Says

Psychedelics Investing
Trending

Johnson & Johnson to Expand Neuroscience Portfolio with US$14.6 Billion Acquisition

Pharmaceutical Investing

Pharma Market Forecast: Top Trends for Pharma in 2025

Pharmaceutical Investing

5 Best-performing Canadian Pharma Stocks (Updated January 2025)

Pharmaceutical Investing
pharmaceutical News
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

Geography
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Geography
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Announces Year-End 2024 Update on Operations

Pharmaceutical Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Geography
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Geography
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Geography
Sirona Biochem (TSXV:SBM)

Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report

Geography
Cardiol Therapeutics (TSX:CRDL)

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Geography
Sirona Biochem (TSXV:SBM)

Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology

Geography
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Geography
International

Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone

SmartNews

Successful Completion of Placement to Accelerate Clinical Programs

SmartNews

ISLA-101 Phase 2a/b PROTECT Clinical Trial Progress Update

SmartNews

InhaleRx Secures $38,500,000 Funding to Fully Fund Clinical Development Plans

SmartNews

Tumour Response in Sixth Patient Triggers Additional Recruitment in Pancreatic Cancer Trial

SmartNews
More pharmaceutical News
Editors' Picks
Pharmaceutical Investing

Harris vs. Trump: The 2024 US Election, Drug Prices and Healthcare

Biotech Investing

How Big Tech is Helping Leverage Big Data in Healthcare

Pharmaceutical Investing

Pharma Market Forecast: Top Trends That Will Affect Pharma in 2024

Latest pharmaceutical News

More pharmaceutical News
×